Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Peanut SLIT for Tolerance in Newly Diagnosed Peanut Allergic Children
NCT02304991Phase 2Completed
- Sponsor
- University of North Carolina at Chapel Hill
- Start
- Jan 2015
- Primary completion
- Dec 2020
- Modality
- Biologic
- Countries
- 1
01
Overview
A Phase 2 trial of peanut extract in peanut allergy, sponsored by University of North Carolina at Chapel Hill. Started Jan 2015; status: completed.
02
Drugs
peanut extract
03
Conditions
peanut allergy
Beyond the preview
Go deeper on NCT02304991.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02304991.